Journal of Medicinal Chemistry p. 1229 - 1235 (1983)
Update date:2022-08-17
Topics:
Sayre
Larson
Fries
Takemori
Portoghese
A series of five epimeric pairs of naltrexone derivatives that contain an electrophilic substituent at the 6α- or 6β-position was synthesized and tested on the guinea pig ileal longitudinal muscle (GPI) and mouse vas deferens (MVD) preparations in order to determine if the orientation of the electrophile is important for covalent bonding to opioid receptors. In the GPI all compounds were pharmacologically active as reversible agonists, but only the 6β-isomers of the fumaramate ester 2b (β-FNA) and isothiocyanate 6b exhibited covalent reactivity, involving a selective irreversible antagonism of the μ agonist, morphine, without affecting κ agonists. The 6α-isomer 2a (α-FNA) was itself nonalkylating but was able to protect the GPI against alkylation by its epimer, β-FNA, indicating that the two epimers bind to the same receptor. These results suggest that the proper orientation of the electrophilic substituent is required for covalent bonding with a proximal nucleophile in the case of μ receptor blockade. Moreover, the lack of covalent bonding to κ receptors by these or other ligands in this series indicates the possible absence of sufficiently reactive nucleophiles on this recognitition site. In the MVD, 2b, but not 2a, irreversibly antagonized morphine (as in GPI), whereas neither epimer exhibited irreversible antagonism toward the δ agonist, [D-Ala2-D-Leu5]enkephalin (DADLE). In contrast, both of the isothiocyanate epimers (6a,b) irreversibly blocked μ and δ receptors. Evidence suggesting differences between μ receptors in the MVD and GPI was obtained with the β-iodoacetamide 5b, which was an irreversible blocker of morphine only in the MVD. When analyzed together with those of previous studies with the nitrogen mustard analogues, α- and β-chlornaltrexamine, the data suggest that the receptor-alkylating ability of each isomer in an epimeric pair differs most when the electrophile possesses a narrow spectrum of reactivity.
View MoreXi'an Kaixiang Photoelectric Technology Co., Ltd
website:http://www.kxmaterials.com/
Contact:86-29-15991651477
Address:Building 6, Biopharmaceutical Industry R&D Cluster Base, No. 16, Caotang 4th Road, Caotang Science and Technology Industrial Base, High-tech Zone, Xi'an City, Shaanxi Province, China
Contact:+8613400661290
Address:No 908,Kangwan Rd, Liuyang Economic
chengdu firsterchem Pharmaceutical Co., Ltd.
Contact:028-66825849
Address:chengdu
Jiangsu Willing Bio-Tech Co ltd
website:http://www.willingbio.com/
Contact:+86 18796909136--
Address:No 18 Guoqiao Road
LIAOYANG WANRONG CHEMICALS COMPANY LIMITED
Contact:86-419-2390789
Address:XINLI VILLAGE , DONG NINGWEI COUNTY,TAIZIHE DISTRICT, LIAOYANG , LIAONING
Doi:10.1016/j.ejmech.2015.12.021
(2016)Doi:10.1002/ejic.201600468
(2016)Doi:10.1007/s11243-019-00351-1
(2020)Doi:10.1039/d0ce00181c
(2020)Doi:10.1039/c2dt32148c
(2013)Doi:10.1524/zpch.2000.214.2.149
(2000)